01

HEMODIALYSIS & EXTRACORPOREAL THERAPY

Chapter 1

Principles of Hemodialysis

Diffusion, Convection & Clearance

Orientation & KnowledgeVisualise & MapClinical ReasoningSafety & EvidencePatient DecisionsApply & Test
Chapter Preamble

This preamble records the dynamic decisions the master makes for this chapter.

Signals declared

  • Sig-M mechanistic (primary) — diffusion, convection, ultrafiltration, and clearance are the chapter.
  • Sig-D diagnostic — it classifies solutes by size and the dialyzer by its properties.

Levels populated and omitted

  • Seventeen levels are built — a foundational physiology chapter with concept maps and implications.
  • Omitted: L14–L17 and L21 — this is a principles chapter, not a therapeutic, decision, or documentation one; the prescription, water treatment, and flux are developed in their own chapters.
Phase A Orientation & Knowledge
01
Phase A · Level 1

Learning Objectives

The contract between this chapter and the reader.

  1. 1. Explain how hemodialysis removes solutes and water across a membrane.
  2. 2. Describe diffusion and what governs its rate.
  3. 3. Describe convection and ultrafiltration.
  4. 4. Define clearance and how it depends on flows and the dialyzer.
  5. 5. Explain countercurrent flow and why it is used.
  6. 6. Describe the hollow-fiber dialyzer and the meaning of flux.
  7. 7. Define the sieving coefficient and the mass-transfer coefficient (KoA).
  8. 8. Classify solutes by size and the mechanism that clears each.
  9. 9. Relate dialysate composition to the gradients it creates.
02
Phase A · Level 2

Executive Summary

A sixty-second reading. Each bullet stands alone.

  • Hemodialysis removes solutes and water from blood across a semipermeable membrane by diffusion, convection, and ultrafiltration.
  • Blood and dialysate flow countercurrent on opposite sides of the membrane to maximise the gradient.
  • Diffusion moves solute down its concentration gradient; its rate depends on the gradient, membrane permeability, surface area, molecular size, and flows.
  • Small solutes diffuse quickly; larger middle molecules diffuse slowly.
  • Ultrafiltration drives water across the membrane by a transmembrane pressure gradient.
  • Convection drags solutes along with the ultrafiltered water (solvent drag), clearing middle molecules better than diffusion.
  • Clearance is the volume of blood completely cleared of a solute per unit time.
  • Small-solute clearance rises with blood flow, dialysate flow, and dialyzer surface area and KoA — with diminishing returns.
  • The dialyzer is a bundle of hollow fibers with blood inside and dialysate countercurrent outside.
  • Flux describes the membrane's permeability to water and middle molecules; high-flux clears them better.
  • The sieving coefficient is the fraction of a solute carried across by convection.
  • Dialysate composition sets the gradients — low in urea and potassium to remove them, and supplying bicarbonate and calcium.
  • Protein-bound and large solutes are cleared poorly by conventional dialysis.
03
Phase A · Level 3

Main Narrative

The medical core. An expert should agree the principles of hemodialysis are fully covered here.

Why it matters at the bedside

Everything else in this book is built on three simple physical processes: solute moving down a gradient, water pushed by pressure, and solute swept along with that water. Master diffusion, ultrafiltration, and convection — and the clearance they produce — and every prescription, every adequacy target, and every modality choice becomes a logical consequence rather than a rule to memorise.

The two mechanisms, plus ultrafiltration

  • Hemodialysis works across a semipermeable membrane by two solute mechanisms — diffusion and convection — and one water mechanism, ultrafiltration. Blood flows on one side of the membrane and dialysate on the other, in opposite directions (countercurrent), so the driving gradients are kept as large as possible along the whole length of the device.

Diffusion and what governs it

  • Diffusion is solute moving down its concentration gradient — urea and potassium from blood into the low-concentration dialysate, bicarbonate the other way. Its rate rises with the size of the gradient, the membrane's permeability and surface area, and the blood and dialysate flows, and it falls as molecular size increases: small solutes cross readily, middle molecules slowly.

Countercurrent flow

  • Running blood and dialysate in opposite directions keeps a concentration difference at every point along the fiber. In cocurrent flow the two would equilibrate partway and diffusion would stall; countercurrent flow sustains the gradient end to end, which is why every dialyzer is plumbed this way.

Ultrafiltration and convection

  • Ultrafiltration is water driven across the membrane by a transmembrane pressure gradient — this is how fluid is removed. As that water crosses, it drags dissolved solutes with it (solvent drag): convection. Convection clears larger middle molecules far better than diffusion, and its magnitude depends on the volume ultrafiltered and the membrane's sieving coefficient for the solute.

Clearance and its determinants

  • Clearance is the volume of blood completely cleared of a solute per unit time — the common currency of dialysis dose. For small solutes it rises with blood flow, dialysate flow, and the dialyzer's surface area and mass-transfer coefficient (KoA), but with diminishing returns: beyond a point, raising a flow adds little because the membrane or the contact time becomes limiting.

The dialyzer and the membrane

  • A dialyzer is a bundle of thousands of hollow capillary fibers: blood passes inside the fibers, dialysate countercurrent around them, and exchange occurs across the fiber wall. Surface areas are around 1.5–2.5 m², and modern membranes are synthetic (such as polysulfone), chosen for biocompatibility and the desired permeability.

Flux and the sieving coefficient

  • Flux describes how permeable the membrane is to water and middle molecules: high-flux membranes have larger pores and clear water and middle molecules far better than low-flux. The sieving coefficient is the fraction of a given solute that passes across with convection — 1.0 means it crosses freely, 0 means it is completely held back — and it governs how much of that solute convection can remove.

Solute size classes

  • Solutes fall into classes by size: small solutes (urea, potassium, creatinine), cleared mainly by diffusion; middle molecules (such as β₂-microglobulin), cleared mainly by convection and high-flux membranes; and protein-bound or large solutes, which conventional dialysis clears poorly because only the free fraction is available and large molecules cross slowly. Matching the mechanism to the molecule is the heart of dialysis design.

Dialysate and the gradient

  • The dialysate exists to create gradients: it is kept low in urea and potassium so those diffuse out of the blood, and it supplies bicarbonate (to buffer acid) and calcium by reversing the gradient. Sodium is held near plasma to avoid loading the patient. The composition is, in effect, the diffusion gradient made to order.
04
Phase A · Level 4

Reference Tables

Five fully-built tables.

Table A — Transport mechanisms

MechanismDriverClears best
DiffusionConcentration gradientSmall solutes (urea, K)
ConvectionSolvent drag (with ultrafiltration)Middle molecules
UltrafiltrationTransmembrane pressureWater (fluid removal)

Table B — Determinants of diffusive clearance

FactorEffect
Concentration gradientLarger gradient → more diffusion
Membrane KoA / surface areaHigher → more clearance
Molecular sizeLarger → slower diffusion
Blood flow (Qb)Higher → more (diminishing returns)
Dialysate flow (Qd)Higher → more (diminishing returns)
Countercurrent flowMaintains the gradient along the fiber

Table C — Solute size classes

ClassExamplesCleared by
Small solutesUrea, potassium, creatinineDiffusion
Middle moleculesβ₂-microglobulinConvection / high-flux
Protein-boundMany drugs and toxinsPoorly (conventional HD)
Large / proteinAlbuminRetained

Table D — The dialyzer and membrane

FeatureNote
DesignHollow-fiber bundle; blood inside, dialysate countercurrent outside
Surface area~1.5–2.5 m²
KoAMass-transfer-area coefficient (diffusive efficiency)
FluxPermeability to water and middle molecules (low vs high)
Sieving coefficientFraction of a solute carried by convection (0–1)
MembraneSynthetic (e.g., polysulfone); biocompatible

Table E — Dialysate and the gradients it creates

ConstituentGradient role
Urea / potassiumLow in dialysate → diffuse out of blood
BicarbonateHigher → buffer diffuses into blood
CalciumSet to add to (or remove from) the blood
SodiumHeld near plasma to avoid loading

Visualise & Map

Phase B Visualise & Map
05
Phase B · Level 5

Imaging and Algorithm Flowcharts

Figure 1.1 — The hollow-fiber dialyzer
Figure 1.1 — The hollow-fiber dialyzer
Figure 1.2 — Diffusion versus convection
Figure 1.2 — Diffusion versus convection
Flowchart 1.A — Matching mechanism to solute
Flowchart 1.A — Matching mechanism to solute
Flowchart 1.B — Countercurrent versus cocurrent
Flowchart 1.B — Countercurrent versus cocurrent
06
Phase B · Level 6

Concept Maps

Causal chains, each ending in a named action.

Chain 1 — Diffusion of small solutes

Concentration gradient across a permeable membrane → solute diffuses from blood to dialysate → small-solute clearance → ACTION: maximise the gradient with countercurrent flow and adequate dialysate flow.

Chain 2 — Ultrafiltration and convection

Transmembrane pressure → water crosses the membrane (ultrafiltration) → solvent drag carries solutes (convection) → middle-molecule clearance → ACTION: use convection and high-flux when middle molecules matter.

Chain 3 — Countercurrent advantage

Countercurrent flow → a concentration difference at every point along the fiber → diffusion continues end to end → ACTION: always run blood and dialysate countercurrent.

Chain 4 — The limits of flow

Higher blood/dialysate flow and KoA → more clearance, but the membrane and contact time saturate → diminishing returns → ACTION: raise the most effective lever rather than one flow alone.

Chain 5 — Size selects the mechanism

Molecular size rises → diffusion slows sharply → middle molecules need solvent drag → ACTION: match the mechanism (diffusion vs convection) to the solute's size.

07
Phase B · Level 7

Clinical Decision Pathways

Numbered rules. These numbers are the cross-reference handle for the cases and flowcharts.

R1
IF removing small solutes, THEN rely on diffusion — the gradient, the flows, KoA, and surface area.
R2
IF removing middle molecules, THEN rely on convection — a high-flux membrane and ultrafiltration.
R3
IF removing water, THEN use ultrafiltration driven by transmembrane pressure.
R4
IF maximising the diffusion gradient, THEN run blood and dialysate countercurrent.
R5
IF clearance is inadequate, THEN raise blood flow, dialysate flow, or the dialyzer's surface area/KoA — accepting diminishing returns.
R6
IF a solute is protein-bound or large, THEN expect poor clearance by conventional dialysis.
R7
IF choosing a membrane, THEN match its flux to the solutes that must be cleared.
R8
IF setting the dialysate, THEN create the gradient — low urea and potassium to remove them, supplying bicarbonate and calcium.

Clinical Reasoning

Phase C Clinical Reasoning
08
Phase C · Level 8

Clinical Cases

Four cases. Each stops you at a decision before it answers it.

CASE 1STANDARD

The drug that won't dialyseWhy protein binding matters

Presentation

A team expects haemodialysis to clear a highly protein-bound drug in an overdose, but the level barely falls after a session.

Pause and reflect

Before reading on: why does dialysis fail to clear it?

Analysis

Only the free, unbound fraction of a solute can cross the membrane, and a highly protein-bound drug presents almost none of itself for diffusion. Conventional dialysis therefore clears it poorly — a property of the molecule, not a failure of the machine — and an adsorptive technique may be needed instead.

Management plan

  1. Recognise protein binding limits clearance (R6).
  2. Do not rely on conventional HD for it.
  3. Consider an adsorptive technique (see the apheresis chapter).

Teaching points

  • Conventional dialysis clears only the free fraction — protein-bound solutes are largely retained.

Cross-reference: exercises R6.

CASE 2COMPLEX

Middle molecules building upMatching mechanism to size

Presentation

A long-term patient on a low-flux membrane has rising β₂-microglobulin despite an adequate small-solute clearance.

Pause and reflect

Before reading on: why is a middle molecule rising when urea clearance is fine?

Analysis

Small-solute clearance is diffusive and adequate, but β₂-microglobulin is a middle molecule that diffuses poorly; clearing it needs convection across a high-flux membrane. The mechanism, not the dose of small-solute dialysis, is the issue.

Management plan

  1. Recognise the middle-molecule problem (R2).
  2. Use a high-flux membrane / convection (see Chapter 12) (R2, R7).
  3. Don't expect more small-solute dose to help.

Teaching points

  • Adequate urea clearance says nothing about middle molecules — they need convection.

Cross-reference: exercises R2, R7; see Chapter 12.

CASE 3STANDARD

Pushing the blood flowDiminishing returns

Presentation

To raise clearance, a clinician keeps increasing the blood-flow rate and is surprised the urea clearance barely improves at the top end.

Pause and reflect

Before reading on: why doesn't more blood flow keep raising clearance?

Analysis

Clearance rises with blood flow only until the membrane (its KoA and surface area) and contact time become limiting; beyond that, extra flow adds little — diminishing returns. Raising clearance further means a larger or higher-KoA dialyzer, more dialysate flow, or more time, not blood flow alone.

Management plan

  1. Recognise the diminishing-returns ceiling (R5).
  2. Raise dialysate flow / dialyzer size / time instead (R5).
  3. Use the most effective lever for the goal.

Teaching points

  • Clearance is not linear with blood flow — the membrane and contact time cap it.

Cross-reference: exercises R5; see Chapter 9.

CASE 4STANDARD

Plumbed the wrong wayCountercurrent flow

Presentation

A circuit is inadvertently set up with blood and dialysate flowing in the same direction, and clearance is lower than expected.

Pause and reflect

Before reading on: why does same-direction flow reduce clearance?

Analysis

Cocurrent flow lets blood and dialysate concentrations equilibrate partway along the fiber, after which diffusion stalls for lack of a gradient. Countercurrent flow keeps a difference at every point, sustaining diffusion end to end — which is why the dialyzer must be configured countercurrent.

Management plan

  1. Recognise the cocurrent error (R4).
  2. Reconfigure to countercurrent flow (R4).
  3. Confirm the improved gradient.

Teaching points

  • Countercurrent flow sustains the gradient — cocurrent flow lets it equilibrate and stall.

Cross-reference: exercises R4.

09
Phase C · Level 9

Clinical Implications

Every mechanism from Level 3 earns a bedside consequence and an action.

MECHANISM

Diffusion moves solute down a concentration gradient.

WHY IT MATTERS

It clears small solutes efficiently but middle molecules poorly.

ACTION

Maximise the gradient with countercurrent flow and adequate dialysate flow.

MECHANISM

Convection drags solutes with ultrafiltered water.

WHY IT MATTERS

It reaches middle molecules that diffusion leaves behind.

ACTION

Use convection and high-flux when middle molecules matter.

MECHANISM

Countercurrent flow keeps a gradient along the whole fiber.

WHY IT MATTERS

Cocurrent flow would equilibrate and stall.

ACTION

Always plumb the dialyzer countercurrent.

MECHANISM

Clearance saturates as flows rise.

WHY IT MATTERS

Beyond a point, more blood flow adds little.

ACTION

Raise dialysate flow, dialyzer size/KoA, or time rather than flow alone.

MECHANISM

Only the free, small fraction of a solute crosses readily.

WHY IT MATTERS

Protein-bound and large solutes are poorly cleared.

ACTION

Do not rely on conventional dialysis for them.

10
Phase C · Level 10

Clinical Pearls

Exhaustive. Every rule in the chapter is here.

HD removes solute by diffusion + convection, and water by ultrafiltration.
Blood and dialysate run countercurrent to maximise the gradient.
Diffusion: down a concentration gradient; best for small solutes.
Diffusion rate ↑ with gradient, KoA, surface area, flows; ↓ with size.
Ultrafiltration = water across the membrane by transmembrane pressure.
Convection = solvent drag; clears middle molecules.
Clearance = volume of blood fully cleared of a solute per unit time.
Small-solute clearance ↑ with Qb, Qd, KoA, area — diminishing returns.
Dialyzer = hollow fibers; blood inside, dialysate countercurrent outside.
Flux = permeability to water/middle molecules (high vs low).
Sieving coefficient = fraction carried by convection (0–1).
Small solutes → diffusion; middle molecules → convection/high-flux.
Protein-bound and large solutes → poorly cleared.
Dialysate sets the gradient: low urea/K; supplies bicarbonate/Ca; Na near plasma.

Safety & Evidence

Phase D Safety & Evidence
11
Phase D · Level 11

Red Flags and NEVER DO

Panel A — Conceptual red flags

Expecting conventional HD to clear a protein-bound or large toxin — it cannot.
Assuming clearance rises linearly with blood flow — it saturates.
Confusing ultrafiltration (water removal) with clearance (solute removal).
Using a low-flux membrane when middle-molecule clearance is the goal.

Panel B — NEVER DO

NEVERexpect conventional hemodialysis to clear protein-bound or large-molecule toxins.
NEVERrun blood and dialysate cocurrent and expect full efficiency.
NEVERassume doubling the blood-flow rate doubles clearance.
NEVERconfuse ultrafiltration with solute clearance.
NEVERuse a low-flux membrane when the aim is middle-molecule clearance.
12
Phase D · Level 12

Common Pitfalls

Anti-patterns clinicians fall into. Each becomes a Level 22 distractor.

WRONG Expecting HD to clear a protein-bound toxin.
RIGHT Recognise poor clearance; consider adsorption.
WHY Only the free fraction crosses, and it is tiny.
WRONG Assuming clearance scales linearly with blood flow.
RIGHT Expect diminishing returns.
WHY The membrane KoA and contact time become limiting.
WRONG Confusing ultrafiltration with clearance.
RIGHT Keep them distinct — UF removes water, clearance removes solute.
WHY They are different processes with different drivers.
WRONG Running cocurrent flow.
RIGHT Configure countercurrent flow.
WHY Cocurrent flow lets the gradient equilibrate and stall.
WRONG Using low-flux when middle molecules matter.
RIGHT Use a high-flux membrane / convection.
WHY Middle molecules diffuse poorly and need solvent drag.
WRONG Ignoring molecular size when planning clearance.
RIGHT Match the mechanism to the solute's size.
WHY Diffusion slows sharply as size rises.
13
Phase D · Level 13

Evidence Grading

The grade reflects strength of evidence, not importance.

GRADE

A

HIGH CONFIDENCE

The effect is real and the estimate is stable.

RCTs at low risk of bias; multiple concordant prospective cohorts; meta-analyses.

GRADE

B

MODERATE CONFIDENCE

The effect is likely real but may shift with new data.

Observational studies, registries, mechanistic human studies.

GRADE

C

LOW CONFIDENCE

Rests on physiology, reasoning, or consensus rather than outcomes.

Pathophysiological reasoning; extrapolation; consensus without outcomes.

StatementGradeRationale for the grade
Diffusion clears small solutes; convection clears middle molecules.AEstablished membrane physiology.
Countercurrent flow maximises the diffusion gradient.AMass-transfer physics.
Small-solute clearance rises with flows and KoA, with diminishing returns.BKinetic and observational data.
High-flux membranes clear middle molecules better than low-flux.BClearance studies.
Protein-bound solutes are poorly cleared by conventional dialysis.APharmacokinetic principle.
The sieving coefficient governs convective clearance of a solute.AMembrane physiology.

Apply & Test

Phase F Apply & Test
18
Phase F · Level 18

High-Yield Cheat Sheet

Pre-rounds compression. Principles only.

Diffusion = gradient; convection = solvent drag; UF = water.
Countercurrent flow maximises the gradient.
Small solutes → diffusion; middle molecules → convection/high-flux.
Clearance ↑ with Qb, Qd, KoA, area — diminishing returns.
Flux = water/middle-molecule permeability.
Sieving coefficient = convective fraction (0–1).
Protein-bound/large → poorly cleared.
UF removes water; clearance removes solute — don't confuse them.
Dialysate sets the gradient (low urea/K; bicarbonate/Ca; Na near plasma).
KoA = the dialyzer's diffusive efficiency.
Match the mechanism to the molecule's size.
Diffusion slows sharply as molecular size rises.
19
Phase F · Level 19

Flashcards

Active recall. At least one card per objective.

CARD 1

Q. By what processes does hemodialysis remove solutes and water?

Show answer

A. Diffusion and convection remove solutes; ultrafiltration removes water — all across a semipermeable membrane.

DETAILED. Blood and dialysate run countercurrent.

CLINICAL. Each process has a distinct driver.

CARD 2

Q. What governs the rate of diffusion?

Show answer

A. The concentration gradient, membrane permeability and surface area, molecular size, and the blood and dialysate flows.

DETAILED. Small solutes diffuse fast; middle molecules slowly.

CLINICAL. Countercurrent flow sustains the gradient.

CARD 3

Q. What are ultrafiltration and convection?

Show answer

A. Ultrafiltration is water driven across the membrane by transmembrane pressure; convection is the solute dragged along with that water (solvent drag).

DETAILED. Convection clears middle molecules better than diffusion.

CLINICAL. Its magnitude depends on the ultrafiltered volume and sieving coefficient.

CARD 4

Q. What is clearance and what raises it?

Show answer

A. The volume of blood completely cleared of a solute per unit time; for small solutes it rises with blood flow, dialysate flow, surface area, and KoA — with diminishing returns.

DETAILED. Beyond a point, more blood flow adds little.

CLINICAL. It is the common currency of dialysis dose.

CARD 5

Q. Why is countercurrent flow used?

Show answer

A. It keeps a concentration difference at every point along the fiber, so diffusion continues end to end; cocurrent flow would equilibrate and stall.

DETAILED. Every dialyzer is plumbed countercurrent.

CLINICAL. It maximises the effective gradient.

CARD 6

Q. Describe the dialyzer and the meaning of flux.

Show answer

A. A bundle of hollow fibers with blood inside and dialysate countercurrent outside; flux is the membrane's permeability to water and middle molecules.

DETAILED. High-flux membranes clear water and middle molecules better.

CLINICAL. Surface area is around 1.5–2.5 m².

CARD 7

Q. Define the sieving coefficient and KoA.

Show answer

A. The sieving coefficient is the fraction of a solute carried across by convection (0–1); KoA is the dialyzer's mass-transfer-area coefficient — its diffusive efficiency.

DETAILED. A sieving coefficient of 1 crosses freely; 0 is held back.

CLINICAL. KoA, with surface area, sets diffusive clearance.

CARD 8

Q. Classify solutes by size and what clears each.

Show answer

A. Small solutes (urea, K) by diffusion; middle molecules (β₂-microglobulin) by convection/high-flux; protein-bound and large solutes are poorly cleared.

DETAILED. Diffusion slows sharply as size rises.

CLINICAL. Match the mechanism to the molecule.

CARD 9

Q. How does dialysate composition create the gradients?

Show answer

A. It is kept low in urea and potassium so they diffuse out, supplies bicarbonate and calcium by reversing the gradient, and holds sodium near plasma to avoid loading.

DETAILED. The composition is the diffusion gradient made to order.

CLINICAL. It both removes and replaces solutes.

20
Phase F · Level 20

One-Minute Preceptor

Micro-teaching for rounds. Two scenarios, five steps each.

SCENE 1
The undialysable drug
GET A COMMITMENTAsk: “We dialysed him but the drug level barely moved — why?”
PROBE“What fraction of a protein-bound drug can even reach the membrane?”
TEACHOnly the small free fraction — so conventional dialysis clears it poorly; think adsorption.
REINFORCE“Right — binding, not the machine, is the limit.”
CORRECT ERRORSIf they blamed the dose, point to protein binding.
SCENE 2
Cranking the blood pump
GET A COMMITMENTAsk: “He keeps raising the blood flow but clearance barely improves — why?”
PROBE“What becomes limiting at high flows?”
TEACHThe membrane KoA and contact time — diminishing returns; use dialysate flow, dialyzer size, or time.
REINFORCE“Exactly — clearance isn't linear with blood flow.”
CORRECT ERRORSIf they kept raising Qb, redirect to the other levers.
22
Phase F · Level 22

Board-Style Q&A

Nine items, each anchored in this chapter. At least one per objective.

Q 01
Which mechanism removes water during hemodialysis?

Tap an option to check your answer

  • ADiffusion
  • BUltrafiltration
  • CAdsorption
  • DOsmosis across the dialyzer
Q 02
Which factor does NOT increase diffusive clearance of urea?

Tap an option to check your answer

  • AA larger concentration gradient
  • BA higher dialyzer KoA
  • CA larger molecular size
  • DA higher dialysate flow
Q 03
Convection (solvent drag) is most important for clearing:

Tap an option to check your answer

  • AUrea
  • BMiddle molecules such as β₂-microglobulin
  • CPotassium
  • DSodium
Q 04
What best defines clearance?

Tap an option to check your answer

  • AThe volume of water removed per hour
  • BThe volume of blood completely cleared of a solute per unit time
  • CThe transmembrane pressure
  • DThe dialysate flow rate
Q 05
Why are blood and dialysate run countercurrent?

Tap an option to check your answer

  • ATo slow the blood pump
  • BTo maintain a concentration gradient along the whole fiber
  • CTo remove more water
  • DTo reduce anticoagulation
Q 06
What does a high-flux membrane provide compared with low-flux?

Tap an option to check your answer

  • ABetter small-solute clearance only
  • BBetter water and middle-molecule permeability
  • CLess biocompatibility by design
  • DNo difference in clearance
Q 07
The sieving coefficient describes:

Tap an option to check your answer

  • AThe diffusive efficiency of the dialyzer
  • BThe fraction of a solute carried across by convection
  • CThe blood-flow rate
  • DThe dialysate sodium
Q 08
Why does conventional hemodialysis clear a highly protein-bound drug poorly?

Tap an option to check your answer

  • AThe drug is too small
  • BOnly the free, unbound fraction can cross the membrane
  • CDialysate flow is too high
  • DThe membrane is high-flux
Q 09
In Flowchart 1.A, the solute to remove is a middle molecule. The pathway directs you to:

Tap an option to check your answer

  • ARely on diffusion (gradient, flows, KoA)
  • BRely on convection (high-flux / ultrafiltration)
  • CDeclare it unclearable
  • DIncrease dialysate sodium